Clinical TrialsSearch results
Number of results: 482
Recruiting
- A Study to Compare the Efficacy and Safety of Ide-cel with LEN Maintenance Therapy Versus LEN Maintenance Therapy Alone in Adult Participants with NDMM Who Have Suboptimal Response After ASCT
- Multiple Myeloma
- Cook Mark
- 2023-12-24
Not yet recruiting
- Clinical study of MP plus zoledronic acid therapy in newly diagnosed multiple myeloma excluding stem cell transplantation patients
- Multiple Myeloma
- Division of clinial oncology and hematology, Jikei University School of Medicine
- 2009-07-06
Other
- A Study of JNJ-64407564 in Japanese Participants with Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Fujikawa Ei
- 2021-04-01
Other
- A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma (iinnovate-1)
- Multiple Myeloma
- Asato Takayuki
- 2022-12-26
Other
- Combination therapy of melphalan plus prednisolone and zoledronic acid for untreated multiple myeloma patients ineligible for autologous stem cell transplantation
- Multiple Myeloma
- Myeloma Bone Disease Study Group
- 2008-10-17
Other
- Phase I study of RO7187797 in patients with Multiple myeloma.
- Multiple myeloma
- Nanki Toshihiro
- 2022-07-16
Other
- Prospective study of the severity-based treatment protocol for Japanese patients with MPO-ANCA-associated vasculitis
- MPO-ANCA-associated vasculitis
- Research Committe of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan
- 2007-10-30
Other
- Efficacy and Safety of mizoribine for MPO-ANCA associated vasculitis; A multicenter randomized controlled trial (Mizoribin for ANCA RPGN Relapse-Prevention study:MARPGN study)
- MPO-ANCA associated vasculitis
- Department of Nephrology, Division of Clinical Sciences, Faculty of Medicine, University of Tsukuba
- 2007-05-06
Other
- Prospective Ramdomized Trial of Extracranial-intracranial (EC-IC) Bypass Surgery for Adults with Moyamoya Disease with Hemorrhagic Onset
- Moyamoya disease
- JAM Trial executive and steering committee
- 2005-09-13
Other
- Okayama nephrotic syndrome treatment group: Study group for short-term combination therapy of angiotensin-2 receptor blocker and cyclosporine for keeping remission
- Minimal change nephrotic syndrome
- Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
- 2007-02-28